NCT06925282

Brief Summary

The anesthesia and surgical procedures from the time the patient enters the operating room to discharge from the recovery room are identical to those used in conventional airway surgeries performed under general anesthesia with Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE). The time point at which rescue ventilation is required due to a drop in oxygen saturation below 92% during anesthesia will be recorded, and the predictive factors for this event will be investigated.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
23mo left

Started Apr 2025

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress35%
Apr 2025Apr 2028

First Submitted

Initial submission to the registry

March 31, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 13, 2025

Completed
12 days until next milestone

Study Start

First participant enrolled

April 25, 2025

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2027

Expected
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2028

Last Updated

April 24, 2026

Status Verified

April 1, 2025

Enrollment Period

1.8 years

First QC Date

March 31, 2025

Last Update Submit

April 21, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Time to Rescue Ventilation Due to Hypoxemia During Airway Surgery With THRIVE Under General Anesthesia

    The primary outcome is the time from the start of apnea to the initiation of rescue ventilation, defined as the point when oxygen saturation (SpO₂) falls to 92% or below during airway surgery under general anesthesia with Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE). This will be measured using continuously recorded intraoperative data. The aim is to identify clinical predictors (e.g., anatomical and physiological variables) associated with the need for rescue ventilation.

    From the start of apnea to the initiation of rescue ventilation during surgery (intraoperative period)

Secondary Outcomes (4)

  • Lowest Oxygen Saturation After Initiation of Rescue Ventilation

    From the start of apnea to the initiation of rescue ventilation during surgery (intraoperative period)

  • Time to Recovery of SpO₂ to 100% After Rescue Ventilation

    From the start of apnea to the initiation of rescue ventilation during surgery (intraoperative period)

  • End-Tidal CO₂ at the Time of Rescue Ventilation

    From the start of apnea to the initiation of rescue ventilation during surgery (intraoperative period)

  • Predictive Factors for the Requirement of Rescue Ventilation

    From the start of apnea to the initiation of rescue ventilation during surgery (intraoperative period)

Study Arms (1)

THRIVE

Adult patients undergoing airway surgery under general anesthesia with Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE).

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients scheduled to undergo elective airway surgery under general anesthesia with THRIVE at a single tertiary academic hospital. A total of 80 patients will be prospectively enrolled. All participants will receive standard anesthetic care, and data will be collected during the intraoperative period for analysis of factors associated with the requirement for rescue ventilation.

You may qualify if:

  • Adult patients undergoing elective airway surgery under general anesthesia with Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE)
  • Patients who provide written informed consent

You may not qualify if:

  • Patients who decline to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Hospital

Seoul, South Korea

RECRUITING

Central Study Contacts

Kyung Won Shin

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical instructor

Study Record Dates

First Submitted

March 31, 2025

First Posted

April 13, 2025

Study Start

April 25, 2025

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

April 1, 2028

Last Updated

April 24, 2026

Record last verified: 2025-04

Locations